今天我们邀请到了内分泌学家和流行病学家玛丽亚·伊内斯·施密特教授，她来自巴西南里奥格兰德联邦大学医学院。 在本期播客结束时，学习者将能够了解糖尿病前期和中间型高血糖引发的长期心血管与肾脏并发症、如何预防这些并发症，以及糖尿病前期和中间型高血糖新型疗法在防止糖尿病发展方面的应用潜力。 本期播客是《2025 年糖尿病前期、中间型高血糖与糖尿病：诊断指南与管理》继续医学教育计划的一部分，目标受众为内分泌科医生，尤其是糖尿病、糖尿病前期、中间型高血糖、肥胖管理及全科医疗领域的临床医生。 血管专科医生和心血管科医生也可能对其中某些内容感兴趣。

Hoy conversaremos con Maria Inês Schmidt, endocrinóloga y epidemióloga, profesora de la Facultad de Medicina de la Universidad Federal de Rio Grande do Sul, en Brasil. Al final del pódcast, los oyentes deberían ser capaces de comprender las complicaciones cardiovasculares y renales a largo plazo de la prediabetes y la hiperglucemia intermedia y saber cómo prevenirlas, así como conocer las posibles aplicaciones de los nuevos tratamientos para la prediabetes o hiperglucemia intermedia con el fin de prevenir el desarrollo de la diabetes. Este pódcast forma parte del programa de formación médica continuada «Prediabetes, hiperglucemia intermedia y diabetes: pautas para el diagnóstico y el tratamiento de la diabetes para 2025», dirigido a los médicos que trabajan en endocrinología, en particular en diabetes, prediabetes, hiperglucemia intermedia, tratamiento de la obesidad y medicina general. Algunos contenidos pueden ser de interés para especialistas vasculares y cardiólogos.

Today we will be speaking with Maria Inês Schmidt, endocrinologist and epidemiologist, Professor at the School of Medicine of the Federal University of Rio Grande do Sul, Brazil. At the end of the podcast, learners should be able to understand the long-term cardiovascular and renal complications of pre-diabetes slash intermediate hyperglycaemia and how to prevent them as well as understand the potential applications of new pre-diabetic slash intermediate hyperglycaemia treatments to prevent diabetes development. This podcast is part of the continuing medical education programme entitled “Prediabetes Intermediate Hyperglycaemia and Diabetes: Diagnosis Guidelines and Management for 2025” targeting clinicians involved in endocrinology, particularly diabetes, prediabetes, intermediate hyperglycaemia, obesity management and general practise. Some content may be of interest to vascular specialists and cardiologists.

Today we will be speaking with Francjan van Spronsen who leads the Division of Inherited Metabolic Diseases as Professor in Paediatrics at the Beatrix Children’s Hospital, University Medical Centre of Groningen, University of Groningen in The Netherlands.  At the end of the podcast, learners should be able to Identify the evidence underpinning the key guideline recommendations and recognise the impact of guidelines on patient outcome. This podcast is part of the continuing medical education program entitled “PKU Blended Learning Journey 2025” targeting specialists in paediatric and adult inherited metabolic disorders, dietitians, nutritionists, clinical biochemists and geneticists, basic scientists, psychologists, gynaecologists and obstetricians, nurses and all healthcare professionals helping those with PKU. All materials will be suitable for all geographic regions.

今天，我们将对话 Barbara Lips 冠名医学教授兼梅奥诊所医学研究生院心血管内科顾问医师 Amir Lerman。 收听本期播客后，参与者将通晓 β 受体阻滞剂在心血管疾病管理方面的最新定位指南，并了解针对冠状动脉疾病患者当前建议的治疗方案。 本播客是“2025 年心血管疾病与高血压：从指南到管理”继续医学教育计划的一部分，目标受众为临床医生，包括心脏病医生、内科医生、全科医生、执业护士以及其他负责管理心血管疾病和高血压患者的专业医护人员。

Сегодня мы поговорим с Эмиром Лерманом, профессором медицины в Центре Барбары Липс и консультантом в отделении кардиоваскулярной медицины в Высшей школе медицины при Клинике Мэйо. Прослушав этот подкаст слушатели ознакомятся с новыми рекомендациями по введению бета-блокаторов при лечении сердечно-сосудистых заболеваний, а также узнают современные рекомендации лечения пациентов с ишемической болезнью сердца. Этот подкаст — часть программы непрерывного медицинского образования под названием «Сердечно-сосудистые заболевания и артериальная гипертензия, 2025 г., от рекомендаций к лечению», ориентированной на клиницистов, в том числе кардиологов, терапевтов и врачей общей практики, практикующих медсестер и других специалистов сферы здравоохранения, участвующих в лечении пациентов с сердечно-сосудистыми заболеваниями и гипертензией.

Today we will be speaking with Amir Lerman, an endowed named Barbara Lips Professor of Medicine and a consultant in the Department of Cardiovascular Medicine at the Mayo Clinic Graduate School of Medicine. After listening to this podcast, participants will be able to be familiar with the new guidance on positioning of beta blockers in cardiovascular disease management and be informed about current recommended treatments for patients with coronary artery disease. This podcast is part of the continuing medical education program entitled, ‘Cardiovascular Disorders and Hypertension 2025, from Guidelines to Management’, targeting clinicians, including cardiologists, internists and general practitioners, nurse practitioners and other healthcare professionals who manage patients with cardiovascular disease and hypertension.

今天，我们将对话 Paul Ladenson，约翰霍普金斯大学医学院内分泌学约翰·伊格·霍华德教授，医学、病理学、肿瘤学、放射学与放射科学及国际卫生教授，并且也是该校的杰出教授。 在本期播客结束时，参与者将能够了解甲状腺功能减退与心血管疾病之间的关系，为甲状腺功能减退和亚临床甲状腺功能减退患者设计护理计划，特别是那些患有影响其他器官疾病的患者，并识别哪些患者将受益于 LT4 治疗。 本播客是“2025 年甲状腺功能减退：对生殖、肾脏、肝脏和心血管健康的影响”继续医学教育计划的一部分，目标受众为内分泌学家以及其他参与甲状腺疾病诊断和管理的医疗保健专业人士。

Hoy hablaremos con Paul Ladenson, quien ocupa la cátedra John Eager Howard de Endocrinología y es profesor de Medicina, Patología, Oncología, Radiología y Ciencias Radiológicas, así como de Salud Internacional en la Facultad de Medicina de la Universidad Johns Hopkins, donde también es profesor distinguido de la universidad. Al final del pódcast, los oyentes deberían ser capaces de comprender la relación entre hipotiroidismo y enfermedad cardiovascular, crear planes de atención para pacientes con hipotiroidismo e hipotiroidismo subclínico, en especial aquellos con afecciones que afectan a otros órganos, e identificar a los pacientes que se beneficiarían del tratamiento con LT4. Este pódcast forma parte del programa de educación médica continua «Hipotiroidismo 2025: impacto en la salud reproductiva, renal, hepática y cardiovascular», dirigido a endocrinólogos y otros profesionales sanitarios que participan en el diagnóstico y tratamiento de los trastornos tiroideos.

Today we will be speaking with Paul Ladenson, John Eager Howard Professor of Endocrinology and Professor of Medicine, Pathology, Oncology, Radiology and Radiological Science, and International Health at Johns Hopkins University School of Medicine, where he is also a University Distinguished Professor.  At the end of the podcast, learners should be able to understand the relationship between hypothyroidism and cardiovascular disease, design care plans for patients with hypothyroidism and subclinical hypothyroidism, especially those with conditions impacting other organs, and identify patients who would benefit from LT4 therapy. This podcast is part of the continuing medical education programme entitled “Hypothyroidism 2025: Impact on Reproductive, Renal, Hepatic and Cardiovascular Health”, targeting endocrinologists and other healthcare professionals involved in the diagnosis and management of thyroid disorders.

Today we will be speaking with Laurie Bernstein, Professor Emerita in the Department of Pediatrics, and past Director of the IMD Nutrition Clinic, Section of Clinical Genetics and Metabolism at the University of Colorado School of Medicine, Denver, and Children’s Hospital Colorado in Aurora, Colorado. At the end of the podcast, learners should identify the challenges of an adolescent brain with PKU management, discuss the current recommendations on independence around diet management and identify hot and cold cognition. This podcast is part of the continuing medical education program entitled “PKU Blended Learning Journey 2025” targeting specialists in paediatric and adult inherited metabolic disorders, dietitians, nutritionists, clinical biochemists and geneticists, basic scientists, psychologists, gynaecologists and obstetricians, nurses and all healthcare professionals helping those with PKU. All materials will be suitable for all geographic regions.

今天，我们很荣幸邀请到法国巴黎西岱大学的临床药理学教授 Rosa Maria Bruno 女士进行交流。 在本期播客结束时，参与者将了解到最新消息以及欧洲高血压学会2023 年版和欧洲心脏病学会 2024 年版的最新指南，熟悉关于 β 受体阻滞剂在心血管疾病管理中定位的最新指南，并掌握顽固性高血压管理的定义和最新思路。 本播客是“2025 年心血管疾病与高血压：从指南到管理”继续医学教育计划的一部分，目标受众为临床医生，包括心脏病医生、内科医生、全科医生、执业护士以及其他负责管理心血管疾病和高血压患者的专业医护人员。  

Сегодня мы поговорим с Розой Марией Бруно, профессором клинической фармакологии Университета Париж Сите, Париж, Франция. К концу этого подкаста участники будут в курсе обновлений и последних рекомендаций Европейского общества гипертензии 2023 года и Европейского общества кардиологов 2024 года, ознакомятся с новыми рекомендациями по позиционированию бета-блокаторов в лечении сердечно-сосудистых заболеваний, а также узнают об определении и последних соображениях в отношении лечения резистентной артериальной гипертензии. Этот подкаст — часть программы непрерывного медицинского образования под названием «Сердечно-сосудистые заболевания и артериальная гипертЕнзия, 2025 г.: от рекомендаций к лечению», ориентированной на клиницистов, в том числе кардиологов, терапевтов и врачей общей практики, практикующих медсестер и других специалистов сферы здравоохранения, участвующих в лечении пациентов с сердечно-сосудистыми заболеваниями и гипертензией.

Today we will be speaking with Rosa Maria Bruno, professor in Clinical Pharmacology at Université Paris Cité, Paris, France. At the end of this podcast, participants will be able to have knowledge of the updates and latest European Society of Hypertension twenty twenty-three and European Society of Cardiology twenty twenty-four guidance, be familiar with the new guidance on positioning of beta-blockers in cardiovascular disease management and be aware of the definition of and latest thinking on the management of resistant hypertension. This podcast is part of the continuing medical education program entitled “Cardiovascular disorders and hypertension twenty twenty-five: from guidelines to management”, targeting clinicians (including cardiologists, internists, and general practitioners), nurse practitioners and other health care professionals who manage patients with cardiovascular disease and hypertension.

今天，我们请到的是佐治亚州亚特兰大埃默里大学医学院内分泌学系医学教授兼 2022 年美国糖尿病协会主席 Guillermo Umpierrez. 本播客是名为“2025 年糖尿病前期/中度高血糖症和糖尿病诊断、指导和管理”的继续医学教育计划的一部分，主要针对内分泌科临床医生，尤其是糖尿病、糖尿病前期、中度高血糖症、肥胖管理和全科实践。 血管专家和心脏病专家可能会对一些内容感兴趣。

Hoy hablaremos con Guillermo Umpierrez, catedrático de Medicina del departamento de Endocrinología de la Facultad de Medicina de la Universidad Emory de Atlanta (Georgia), y presidente de la Asociación Americana de la Diabetes en 2022. Este pódcast forma parte del programa de formación médica continuada «Prediabetes e hiperglucemia intermedia y diagnóstico, pautas y tratamiento de la diabetes para 2025», dirigido a los médicos que trabajan en endocrinología, en particular en diabetes, prediabetes, hiperglucemia intermedia, tratamiento de la obesidad y medicina general. Algunos contenidos pueden ser de interés para especialistas vasculares y cardiólogos.

Today, we will be speaking with Guillermo Umpierrez, Professor of Medicine in the Division of Endocrinology at Emory University School of Medicine in Atlanta, Georgia, and the twenty twenty-two President of the American Diabetes Association. This podcast is part of the continuing medical education program entitled “Pre diabetes/intermediate hyperglycaemia and diabetes: diagnosis, guidelines and management for twenty twenty-five” targeting clinicians involved in endocrinology, particularly diabetes, pre-diabetes/IH; obesity management and general practice. Some content of interest to vascular specialists and cardiologists.

今天，我们很荣幸邀请到丹麦哥本哈根大学医院肾脏与内分泌疾病科及妇科与产科系医学博士兼全职研究员 Sophie Bliddal 进行交流。 在本期播客结束时，学习者应能熟练掌握妊娠期甲状腺功能减退症的诊疗。 本播客是“2025 年甲状腺功能减退症：对生殖、肾脏、肝脏及心血管健康的影响”继续医学教育计划的一部分，其目标受众为从事甲状腺疾病诊断与管理的内分泌科医生及其他专业医疗人员。

Hoy hablaremos con Sophie Bliddal, médica e investigadora a tiempo completo en el Departamento de Enfermedades Renales y Endocrinas y el Departamento de Ginecología y Obstetricia del Hospital Universitario de Copenhague, en Dinamarca. Al final de este pódcast, los oyentes deberían ser capaces de abordar con competencia el hipotiroidismo durante el embarazo. Este pódcast forma parte del programa de educación médica continua «Hipotiroidismo en 2025: impacto en la salud reproductiva, renal, hepática y cardiovascular», dirigido a endocrinólogos y otros profesionales sanitarios que participan en el diagnóstico y tratamiento de los trastornos tiroideos.

Today, we will be speaking with Sophie Bliddal, medical doctor and full-time researcher from the Department of Kidney and Endocrine Disease and the Department of Gynaecology and Obstetrics, Copenhagen University Hospital, Denmark. At the end of this podcast, learners should be able to competently manage hypothyroidism in pregnancy. This podcast is part of the continuing medical education programme entitled “Hypothyroidism 2025: Impact on Reproductive, Renal, Hepatic and Cardiovascular Health”, targeting endocrinologists and other healthcare professionals involved in the diagnosis and management of thyroid disorders.